NCT04148989

Brief Summary

Sepsis is a life-threatening complication of infection that can be difficult to recognize and treat promptly. Timely administration of antibiotics for emergency department (ED) patients with sepsis is challenging. The goal of this study is to determine the potential effectiveness and unintended consequences of reorganizing ED care for patients with suspected sepsis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180,402

participants targeted

Target at P75+ for not_applicable sepsis

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 13, 2018

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 4, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2023

Completed
2 months until next milestone

Results Posted

Study results publicly available

March 5, 2024

Completed
Last Updated

March 5, 2024

Status Verified

February 1, 2024

Enrollment Period

4.2 years

First QC Date

October 31, 2019

Results QC Date

January 11, 2024

Last Update Submit

February 7, 2024

Conditions

Keywords

SepsisClinical ProtocolsEmergency Medicine

Outcome Measures

Primary Outcomes (1)

  • Door-to-antibiotic Time

    Time from sepsis patients' emergency department arrival to intravenous (or equivalent) antibiotic initiation

    Up to 24 hours from ED arrival (an average of 3 hours)

Secondary Outcomes (5)

  • All-cause 30-day Mortality

    30 days after ED arrival

  • All-cause 1-year Mortality

    1 year after ED arrival

  • All-cause In-hospital Mortality

    From the time of admission to hospital discharge (up to 1 year, average 14 days)

  • Hospital Charges

    From the time of admission to hospital discharge (up to 1 year, average 14 days)

  • Hospital Length of Stay

    From the time of admission to hospital discharge (up to 1 year, average 14 days)

Other Outcomes (8)

  • Antibiotic Utilization'

    Up to 24 hours from ED arrival (an average of 6 hours)

  • Adverse Effects of Antibiotics (Sepsis Patients)

    From the time of ED arrival to hospital discharge (up to 1 year, average 14 days)

  • Adverse Effect of Antibiotics (All ED Patients)

    From the time of ED arrival to hospital discharge (up to 1 year, average 14 days)

  • +5 more other outcomes

Study Arms (4)

Pre-implementation usual care (intervention site)

NO INTERVENTION

Adult patients age ≥18 years who receive usual care after presenting to the ED of the intervention hospital emergency department before implementation of sepsis care reorganization (Code Sepsis implementation). The primary analysis will focus on the subset of patients with sepsis.

Code Sepsis post-implementation (intervention site)

EXPERIMENTAL

Adult patients age ≥18 years presenting to the ED of the intervention hospital emergency department after implementation of sepsis care reorganization (Code Sepsis implementation). The primary analysis will focus on the subset of patients with sepsis.

Other: Code Sepsis protocol (full implementation)

Pre-implementation usual care (control sites)

NO INTERVENTION

Adult patients age ≥18 years who receive usual care after presenting to the ED of the control hospital emergency department before implementation of sepsis care reorganization (Code Sepsis implementation) at the intervention hospital. The primary analysis will focus on the subset of patients with sepsis.

Post-implementation usual care (control sites)

NO INTERVENTION

Adult patients age ≥18 years who receive usual care after presenting to the ED of the control hospital emergency department after implementation of sepsis care reorganization (Code Sepsis implementation) at the intervention hospital. The primary analysis will focus on the subset of patients with sepsis.

Interventions

Implementation of a coordinated, structured, multidisciplinary team-based protocol for initial evaluation and treatment of ED patients with suspected sepsis.

Code Sepsis post-implementation (intervention site)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (age ≥18 years)
  • ED patient at Intermountain Medical Center, Utah Valley Hospital, Dixie Regional Medical Center
  • Arrival to study emergency department (ED) during study period of 11/13/2018 to 2/12/2021.

You may not qualify if:

  • (1) Trauma patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Intermountain Medical Center

Murray, Utah, 84107, United States

Location

Utah Valley Hospital

Provo, Utah, 84604, United States

Location

Dixie Regional Medical Center

St. George, Utah, 84790, United States

Location

Related Publications (1)

  • Peltan ID, Bledsoe JR, Jacobs JR, Groat D, Klippel C, Adamson M, Hooper GA, Tinker NJ, Foster RA, Stenehjem EA, Moores Todd TD, Balls A, Avery J, Brunson G, Jones J, Bair J, Dorais A, Samore MH, Hough CL, Brown SM. Effectiveness and Safety of an Emergency Department Code Sepsis Protocol: A Pragmatic Clinical Trial. Ann Am Thorac Soc. 2024 Nov;21(11):1560-1571. doi: 10.1513/AnnalsATS.202403-286OC.

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Director, Office of Research
Organization
Intermountain Health

Study Officials

  • Ithan Peltan, MD

    Intermountain Health Care, Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Patients presenting to the intervention emergency department after implementation of the care reorganization intervention - "Code Sepsis protocol" - will be compared to patients presenting prior to the intervention. Patients presenting to control emergency departments will receive usual care both before and after Code Sepsis implementation and are included in this study to control for changes in intervention-site outcomes over time unrelated to the tested intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Investigator

Study Record Dates

First Submitted

October 31, 2019

First Posted

November 4, 2019

Study Start

November 13, 2018

Primary Completion

January 23, 2023

Study Completion

December 28, 2023

Last Updated

March 5, 2024

Results First Posted

March 5, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

In order to protect patient privacy and comply with relevant regulations, identified data will be unavailable. Requests for deidentified data from qualified researchers with appropriate ethics board approvals and relevant data use agreements will be processed by the Intermountain Office of Research, officeofresearch@imail.org.

Locations